bioMérieux revenue and financials
In the fiscal year ended December 2025, bioMérieux reported revenue of €4.07B (+2.26% year over year). Net income was €397.5M, a net margin of 9.8%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +2.26%
- 2025 vs 2024
- Net income growth
- −8.03%
- 2025 vs 2024
- Net margin
- 9.8%
- 2024: 10.9%
How bioMérieux is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 5.5% a year on average over the last 5 years
Compound annual growth rate: from €3.12B in 2020 to €4.07B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Free cash flow equal to 74% of net income
Totals for fiscal years 2023–2025: free cash flow €881.7M, net income €1.19B.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,070 | 3,980 | 3,675 | 3,589 | 3,376 | 3,118 | 2,675 | 2,421 | 2,288 | 2,103 |
| Cost of revenue | 1,761 | 1,765 | 1,617 | 1,580 | 1,375 | 1,365 | 1,208 | 1,119 | 1,076 | 1,003 |
| Gross profit | 2,309 | 2,215 | 2,057 | 2,009 | 2,001 | 1,754 | 1,467 | 1,302 | 1,212 | 1,101 |
| Selling, general and administrative | 1,111 | 1,098 | 1,021 | 955 | 816 | 789 | 750 | 643 | 604 | 570 |
| Research and development | 507 | 492 | 460 | 447 | 386 | 399 | 374 | 327 | 304 | 272 |
| Operating income | 695 | 638 | 569 | 613 | 814 | 613 | 388 | 364 | 335 | 298 |
| EBIT | 695 | 638 | 569 | 613 | 814 | 613 | 388 | 364 | 335 | 298 |
| EBITDA | 1,130 | 948 | 858 | 853 | 1,005 | 797 | 551 | 519 | 475 | 439 |
| Interest expense | 15.8 | 16.0 | 15.8 | 4.1 | 9.1 | 24.9 | 20.1 | 19.7 | 16.1 | 17.1 |
| Pre-tax income | 526 | 579 | 437 | 581 | 774 | 524 | 348 | 321 | 292 | 259 |
| Income tax | 129 | 154 | 115 | 140 | 176 | 122 | 77.8 | 65.1 | 54.5 | 79.8 |
| Net income | 398 | 432 | 358 | 452 | 601 | 404 | 273 | 257 | 238 | 179 |
| Net income to common shareholders | 398 | 432 | 358 | 452 | 601 | 404 | 273 | 257 | 238 | 179 |
| Basic EPS | 3.37 | 3.67 | 3.03 | 3.84 | 5.08 | 3.42 | 2.31 | 2.18 | 2.02 | 1.51 |
| Diluted EPS | 3.34 | 3.64 | 3.01 | 3.82 | 5.06 | 3.41 | 2.30 | 2.17 | 2.01 | 1.51 |
| Average shares (basic) | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 |
| Average shares (diluted) | 119 | 119 | 119 | 118 | 119 | 119 | 119 | 118 | 118 | 118 |
| Dividend per share | 0.98 | 0.90 | 0.85 | 0.85 | 0.85 | 0.62 | 0.19 | 0.35 | 0.34 | 0.33 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,965 | 2,026 | 2,044 | 2,078 | 1,902 | 1,905 | 1,770 | 1,931 | 1,658 | 1,802 |
| Cost of revenue | 866 | 884 | 877 | 926 | 839 | 847 | 771 | 860 | 720 | 722 |
| Gross profit | 1,098 | 1,142 | 1,167 | 1,153 | 1,063 | 1,058 | 999 | 1,071 | 938 | 1,080 |
| Selling, general and administrative | 544 | 542 | 569 | 561 | 536 | 518 | 502 | 514 | 440 | 437 |
| Research and development | 257 | 258 | 249 | 251 | 241 | 234 | 227 | 239 | 207 | 205 |
| Operating income | 299 | 341 | 354 | 350 | 288 | 298 | 271 | 291 | 322 | 433 |
| EBIT | 299 | 341 | 354 | 350 | 288 | 298 | 271 | 291 | 322 | 433 |
| EBITDA | 416 | 654 | 495 | 524 | 424 | 464 | 394 | 430 | 422 | 534 |
| Interest expense | 7.7 | 8.4 | 7.4 | 8.0 | 8.0 | 11.8 | 4.0 | — | 4.9 | 5.4 |
| Pre-tax income | 295 | 313 | 213 | 296 | 283 | 229 | 208 | 289 | 292 | 415 |
| Income tax | 68.8 | 76.2 | 52.6 | 85.8 | 68.5 | 44.9 | 69.6 | 74.9 | 65.2 | 93.1 |
| Net income | 226 | 237 | 161 | 217 | 215 | 196 | 162 | 224 | 228 | 324 |
| Net income to common shareholders | 226 | 237 | 161 | 217 | 215 | 196 | 162 | 224 | 228 | 324 |
| Basic EPS | 1.92 | 2.01 | 1.36 | 1.84 | 1.83 | 1.66 | 1.37 | 1.91 | 1.93 | 2.74 |
| Diluted EPS | 1.91 | 1.99 | 1.35 | 1.82 | 1.82 | 1.65 | 1.36 | 1.89 | 1.93 | 2.73 |
| Average shares (basic) | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 | 118 |
| Average shares (diluted) | 118 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 118 | 119 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5,575 | 5,770 | 5,259 | 5,187 | 4,605 | 3,928 | 3,782 | 3,504 | 2,990 | 3,029 |
| Current assets | 2,540 | 2,501 | 2,205 | 2,217 | 2,193 | 1,662 | 1,439 | 1,315 | 1,282 | 1,183 |
| Cash and equivalents | 570 | 450 | 352 | 553 | 804 | 389 | 275 | 288 | 312 | 179 |
| Receivables | 943 | 939 | 860 | 857 | 709 | 682 | 640 | 578 | 549 | 563 |
| Inventory | 960 | 1,037 | 909 | 737 | 620 | 542 | 495 | 419 | 380 | 404 |
| Net property, plant and equipment | 1,657 | 1,696 | 1,506 | 1,370 | 1,225 | 1,069 | 1,025 | 899 | 711 | 735 |
| Goodwill | 728 | 730 | 699 | 813 | 670 | 629 | 653 | 603 | 443 | 471 |
| Other intangible assets | 402 | 492 | 529 | 625 | 412 | 431 | 508 | 526 | 431 | 493 |
| Long-term investments | 114 | 180 | 206 | 71.2 | 34.5 | 39.9 | 31.7 | 59.2 | 51.0 | 31.2 |
| Current liabilities | 1,065 | 1,135 | 1,087 | 1,131 | 956 | 924 | 1,170 | 796 | 652 | 760 |
| Accounts payable | 262 | 272 | 265 | 269 | 240 | 207 | 212 | 180 | 161 | 176 |
| Long-term debt | 211 | 207 | 234 | 225 | 265 | 249 | 49.2 | 413 | 353 | 325 |
| Total debt | 441 | 473 | 490 | 452 | 436 | 428 | 581 | 644 | 416 | 421 |
| Total liabilities | 1,469 | 1,559 | 1,507 | 1,544 | 1,441 | 1,446 | 1,527 | 1,502 | 1,253 | 1,408 |
| Total equity (incl. minority) | 4,106 | 4,211 | 3,752 | 3,643 | 3,164 | 2,481 | 2,255 | 2,002 | 1,737 | 1,621 |
| Retained earnings | 398 | 432 | 358 | 452 | 601 | 404 | 273 | 257 | 238 | 179 |
| Minority interest | 3.9 | 6.1 | 0.0 | 38.7 | 51.4 | 50.2 | 50.7 | 74.0 | -0.9 | 2.2 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5,694 | 5,575 | 5,366 | 5,770 | 5,319 | 5,259 | 5,031 | 5,187 | 5,041 | 4,605 |
| Current assets | 2,595 | 2,540 | 2,277 | 2,501 | 2,213 | 2,205 | 2,153 | 2,217 | 2,066 | 2,193 |
| Cash and equivalents | 658 | 570 | 381 | 450 | 272 | 352 | 423 | 553 | 524 | 804 |
| Receivables | 962 | 943 | 923 | 939 | 928 | 860 | 889 | 857 | 826 | 709 |
| Inventory | 975 | 960 | 974 | 1,037 | 1,013 | 909 | 841 | 737 | 709 | 620 |
| Net property, plant and equipment | 1,709 | 1,657 | 1,593 | 1,696 | 1,576 | 1,506 | 1,392 | 1,370 | 1,314 | 1,225 |
| Goodwill | 757 | 728 | 728 | 730 | 718 | 699 | 734 | 813 | 878 | 670 |
| Other intangible assets | 415 | 402 | 411 | 492 | 527 | 529 | 593 | 625 | 668 | 412 |
| Long-term investments | 122 | 114 | 163 | 180 | 155 | 206 | 89.2 | 71.2 | 48.0 | 34.5 |
| Current liabilities | 1,128 | 1,065 | 1,005 | 1,135 | 1,001 | 1,087 | 981 | 1,131 | 1,021 | 956 |
| Accounts payable | 252 | 262 | 229 | 272 | 216 | 265 | 244 | 269 | 243 | 240 |
| Long-term debt | 66.2 | 211 | 213 | 207 | 237 | 234 | 232 | 225 | 272 | 265 |
| Total debt | 419 | 441 | 473 | 473 | 494 | 490 | 458 | 452 | 501 | 436 |
| Total liabilities | 1,395 | 1,469 | 1,428 | 1,559 | 1,439 | 1,507 | 1,389 | 1,544 | 1,527 | 1,441 |
| Total equity (incl. minority) | 4,299 | 4,106 | 3,938 | 4,211 | 3,880 | 3,752 | 3,642 | 3,643 | 3,514 | 3,164 |
| Retained earnings | 226 | 398 | 161 | 432 | 215 | 358 | 162 | 452 | 1,292 | 601 |
| Minority interest | 2.1 | 3.9 | 4.0 | 6.1 | 12.3 | — | 14.2 | 38.7 | 44.9 | 51.4 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 788 | 667 | 445 | 475 | 825 | 583 | 408 | 400 | 341 | 336 |
| Depreciation and amortization | 473 | 344 | 318 | 269 | 220 | 209 | 187 | 177 | 140 | 141 |
| Capital expenditure | -335 | -346 | -338 | -287 | -290 | -278 | -273 | -226 | -184 | -233 |
| Investing cash flow | -462 | -360 | -489 | -528 | -307 | -265 | -282 | -413 | -180 | -257 |
| Financing cash flow | -155 | -213 | -122 | -244 | -141 | -176 | -134 | 43.0 | -52.5 | -52.5 |
| Dividends paid | -106 | -100 | -100 | -101 | -73.1 | -22.5 | -41.3 | -40.2 | -39.4 | -39.5 |
| Share repurchases | -18.2 | -37.6 | — | -157 | -17.4 | -18.4 | — | -22.3 | -0.9 | -14.1 |
| Debt issued | 33.6 | 9.8 | 38.9 | 67.7 | 18.2 | 292 | — | 106 | — | 18.6 |
| Debt repaid | -63.2 | -84.6 | -73.7 | -53.4 | -68.3 | -427 | -69.2 | — | -0.6 | — |
| Effect of exchange rates | -48.4 | 13.9 | -29.7 | 38.7 | 39.2 | -34.1 | -6.1 | -11.8 | 5.4 | -15.9 |
| Net change in cash | 123 | 109 | -195 | -259 | 416 | 107 | -14.3 | 17.8 | 114 | 10.0 |
| Free cash flow | 453 | 322 | 107 | 188 | 535 | — | — | — | — | — |
| Levered free cash flow | 616 | 298 | 152 | 206 | 389 | 283 | 102 | 227 | 120 | 103 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 437 | 471 | 320 | 470 | 197 | 298 | 148 | 324 | 151 | 539 |
| Depreciation and amortization | 133 | 335 | 140 | 208 | 136 | 195 | 123 | 168 | 100 | 129 |
| Capital expenditure | -140 | -183 | -153 | -196 | -150 | -188 | -150 | -150 | -137 | -147 |
| Investing cash flow | -166 | -182 | -282 | -192 | -168 | -342 | -147 | -176 | -352 | -164 |
| Financing cash flow | -199 | -78.9 | -76.5 | -97.3 | -115 | -16.2 | -106 | -117 | -128 | -66.8 |
| Dividends paid | — | -106 | -106 | 0.0 | -100 | — | -100 | 0.0 | -101 | 0.0 |
| Share repurchases | -19.3 | -34.6 | — | -16.4 | -21.2 | -4.6 | — | -45.9 | -111 | -14.9 |
| Debt issued | 0.6 | -0.6 | 34.2 | -35.9 | 45.7 | 22.5 | 16.4 | -34.7 | 102 | -12.6 |
| Debt repaid | -64.6 | -42.2 | -21.0 | -45.1 | -39.5 | -34.1 | -39.6 | -35.8 | -17.6 | -39.3 |
| Effect of exchange rates | 17.9 | -1.5 | -46.9 | 8.5 | 5.4 | -6.7 | -23.0 | -16.5 | 55.2 | 26.4 |
| Net change in cash | 89.8 | 208 | -85.1 | 190 | -80.9 | -67.4 | -128 | 15.4 | -274 | 335 |
| Free cash flow | 297 | 288 | 167 | 275 | 46.9 | 110 | -2.4 | 175 | 13.8 | 392 |
| Levered free cash flow | 185 | 407 | 211 | 321 | -23.3 | 194 | -41.7 | 254 | -48.1 | 334 |
Financial statements of similar companies
Companies in the group: same industry, similar size
